Maternal serum screening for fetal Down syndrome: Clinical aspects

Clinical Obstetrics and Gynecology

Volumn 39, Issue 4, 1996, Pages 783-792

  Saller Jr , Devereux N ^a   Canick, Jacob A ^b  

^a STRONG MEMORIAL HOSPITAL   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; CHORIONIC GONADOTROPIN ALPHA SUBUNIT; CHORIONIC GONADOTROPIN BETA SUBUNIT; ESTRADIOL; ESTRIOL; GLUCURONIDE; GLYCOPROTEIN; GONADOTROPIN; HUMAN PLACENTA LACTOGEN; HYPOPHYSIS HORMONE; INHIBIN; PREGNANCY ASSOCIATED PLASMA PROTEIN A; PROGESTERONE;

AMNIOCENTESIS; CHORION VILLUS SAMPLING; CONGENITAL MALFORMATION; DOWN SYNDROME; ECHOGRAPHY; FETUS; FIRST TRIMESTER PREGNANCY; GENETIC SCREENING; GESTATIONAL AGE; HIGH RISK POPULATION; HUMAN; INFORMED CONSENT; MATERNAL AGE; MATERNAL SERUM; MULTIPLE PREGNANCY; NEURAL TUBE DEFECT; PRENATAL DIAGNOSIS; REVIEW; RISK; SECOND TRIMESTER PREGNANCY;

ALPHA-FETOPROTEINS; DECISION TREES; DOWN SYNDROME; FEMALE; GENETIC SCREENING; HUMANS; MATERNAL AGE; PREGNANCY; PREGNANCY, HIGH-RISK; PRENATAL DIAGNOSIS; RISK FACTORS;

EID: 10544240358     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003081-199612000-00007     Document Type: Review

References (11)

1. Merkatz IK, Nitowsky HM, Macri JN, et al. An association between low maternal serum alpha-fetoprotein and fetal chromosome abnormalities. Am J Obstet Gynecol. 1984;148:886-894.
2. Cuckle HS, Wald NJ, Lindenbaum RH. Maternal serum alpha-fetoprotein measurement: a screening test for Down's syndrome. Lancet. 1984;1:926-929.
3. Canick JA, Knight GJ, Palomaki GE, et al. Low second trimester maternal serum estriol in Down syndrome pregnancies. Am J Hum Genet. 1987;41:A269.
4. Canick JA, Knight GJ, Palomaki GE, et al. Second trimester maternal serum unconjugated oestriol in pregnancies with Down's syndrome. Br J Obstet Gynaecol. 1988;95:330-333.
5. Bogart MH, Pandian MR, Jones OW. Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities. Prenat Diagn. 1987; 7:623-630.
6. Wald NJ, Cuckle HS, Densem JW. Maternal serum screening for Down's syndrome in early pregnancy. Br Med J. 1988;297:883-887.
7. Haddow JE, Palomaki GE, Knight GJ, et al. Prenatal Screening for Down Syndrome with the Use of Maternal Serum Markers. N Engl J Med. 1992;327:588-593.
8. Mooney RA, Peterson CJ, French CA, et al. Effectiveness of combining maternal serum AFP and human chorionic gonadotropin in a second trimester screening program for down syndrome. Obstet Gynecol. 1994;84: 298-303.
9. Macri JN, Kasturi RV, Krantz DA, et al. Maternal serum Down syndrome screening: free beta protein is a more effective marker than human chorionic gonadotropin. Am J Obstet Gynecol. 1990;163:1248-1253.
10. Wald N, Cuckle H, Wu T, George L. Maternal serum unconjugated oestriol and human chorionic gonadotropin levels in twin pregnancies: implications for screening for Down's syndrome. Br J Obstet Gynaecol. 1991;98:905-908.
11. ACOG Committee Opinion #141, August 1994. Down Syndrome Screening.